HomeCompareCTPCF vs MRK

CTPCF vs MRK: Dividend Comparison 2026

CTPCF yields 5.48% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTPCF wins by $3.54M in total portfolio value
10 years
CTPCF
CTPCF
● Live price
5.48%
Share price
$1.43
Annual div
$0.08
5Y div CAGR
58.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.59M
Annual income
$2,645,548.16
Full CTPCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CTPCF vs MRK

📍 CTPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTPCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTPCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTPCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTPCF
Annual income on $10K today (after 15% tax)
$466.07/yr
After 10yr DRIP, annual income (after tax)
$2,248,715.94/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CTPCF beats the other by $2,240,387.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTPCF + MRK for your $10,000?

CTPCF: 50%MRK: 50%
100% MRK50/50100% CTPCF
Portfolio after 10yr
$1.83M
Annual income
$1,327,673.15/yr
Blended yield
72.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTPCF
No analyst data
Altman Z
-0.3
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTPCF buys
0
MRK buys
0
No recent congressional trades found for CTPCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTPCFMRK
Forward yield5.48%2.76%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR58.5%32.7%
Portfolio after 10y$3.59M$56.8K
Annual income after 10y$2,645,548.16$9,798.13
Total dividends collected$3.48M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTPCF vs MRK ($10,000, DRIP)

YearCTPCF PortfolioCTPCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,569$869.07$11,206$366.19+$363.00CTPCF
2$13,868$1,489.36$12,650$502.35+$1.2KCTPCF
3$17,484$2,644.66$14,407$694.19+$3.1KCTPCF
4$23,646$4,938.87$16,585$967.82+$7.1KCTPCF
5$35,196$9,894.75$19,342$1,363.89+$15.9KCTPCF
6$59,477$21,816.41$22,913$1,947.19+$36.6KCTPCF
7$118,250$54,610.49$27,662$2,823.89+$90.6KCTPCF
8$287,362$160,834.12$34,159$4,173.35+$253.2KCTPCF
9$886,440$578,962.44$43,337$6,308.80+$843.1KCTPCF
10$3,594,039$2,645,548.16$56,776$9,798.13+$3.54MCTPCF

CTPCF vs MRK: Complete Analysis 2026

CTPCFStock

CITIC Limited operates in the financial services, resources and energy, manufacturing, engineering contracting, advanced materials, consumption, and urbanization businesses worldwide. The company's Comprehensive Financial Services segment provides banking, trust, insurance and reinsurance, investment banking, wealth and asset management, financial markets, equity investment, financing, and other integrated financial services. Its Advanced Intelligent Manufacturing segment offers wheels and lightweight cast components, and chassis and body systems; and mining and heavy machinery, specialized robots and intelligent equipment, new energy equipment, and special materials. The company's Advanced Materials segment offers special steel products; and high-grade chloride, as well as explores, develops, and produces oil. It also invests in coal and bauxite mining, import and export of commodities, electrolytic aluminum, and alumina smelting; and invests in and manages power plants. The company's New Consumption segment provides telecommunications services; and leases and sells satellite transponders. It also publishes books and digital books, as well as engages in bookstore retailing business. In addition, this segment deals and distributes with supporting services for automotive brands; and develops agricultural science and technology, as well as engages in the brand development, manufacturing, commodity trading, agency distribution, logistics, and retail in the food and fast-moving consumer goods, healthcare, and electrical products industries. The company's New-Type Urbanisation segment provides environmental and infrastructure, contracting and design, healthcare, and general aviation services; and develops and invests in mixed-use and commercial properties, and residential properties. The company was formerly known as CITIC Pacific Limited and changed its name to CITIC Limited in August 2014. The company was founded in 1987 and is based in Central, Hong Kong.

Full CTPCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CTPCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTPCF vs SCHDCTPCF vs JEPICTPCF vs OCTPCF vs KOCTPCF vs MAINCTPCF vs JNJCTPCF vs ABBVCTPCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.